Literature DB >> 22696708

Actinomycosis and tonsillar disease.

Mahboob Hasan1, Amit Kumar.   

Abstract

A 10-year-old female presented with complaints of submandibular swelling, sore throat, painful deglutition, difficulty in speech and fever. The patient gave history of recurrent tonsillitis associated with snoring and breathing difficulty during sleep. Oral examination revealed inflamed, hypertrophied tonsils and dental caries. Throat swab culture was positive for β-haemolytic streptococci. The patient underwent elective tonsillectomy and histopathological examination revealed characteristic colonies of actinomycetes. The patient was put on intravenous penicillin and after 6 months of follow-up is disease free. The report recommends that histopathological examination must be performed in cases of recurrent tonsillitis with tonsillar hypertrophy. Microscopic examination may reveal actinomycetes which may not be evident on culture; treatment requires a longer course of high-dose penicillins. This further supports the view that actinomycetes have a causal association with recurrent tonsillitis and tonsillar hypertrophy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22696708      PMCID: PMC3091268          DOI: 10.1136/bcr.01.2011.3750

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

1.  Pathologic quiz case 2. Abscess with sulfur granules with organisms consistent with Actinomyces species.

Authors:  D G Becker; C D McKinney; J F Huhn; J F Reibel
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1992-12

2.  The incidence and role of actinomyces in recurrent acute tonsillitis.

Authors:  R Gaffney; M Harrison; M Walsh; E Sweeney; M Cafferkey
Journal:  Clin Otolaryngol Allied Sci       Date:  1993-08

3.  Human actinomycosis. A study of 181 subjects.

Authors:  J R Brown
Journal:  Hum Pathol       Date:  1973-09       Impact factor: 3.466

4.  Sulfur granules. Second thoughts.

Authors:  J R Graybill; B D Silverman
Journal:  Arch Intern Med       Date:  1969-04

5.  Actinomycosis of tonsil masquerading as tumour in a 12-year old child.

Authors:  Samar Pal Singh Yadav; Rakesh Chanda; Geeta Gathwala; Rohtas Kanwar Yadav
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2002-03-15       Impact factor: 1.675

Review 6.  Actinomycosis: diagnostic and therapeutic considerations and a review of 32 cases.

Authors:  D F Bennhoff
Journal:  Laryngoscope       Date:  1984-09       Impact factor: 3.325

7.  Prevalence of tonsillar Actinomyces in children undergoing tonsillectomy for sleep disordered breathing compared with recurrent tonsillitis.

Authors:  Faruque Riffat; Paul Walker
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2009-05-17       Impact factor: 1.675

8.  Actinomycosis in obstructive tonsillar hypertrophy and recurrent tonsillitis.

Authors:  S M Pransky; J I Feldman; D B Kearns; A B Seid; G F Billman
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1991-08

9.  Actinomycosis of faucial tonsil masquerading as oropharyngeal malignancy.

Authors:  Sanjeev Mohanty
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2006-01

10.  Actinomycosis in the etiology of recurrent tonsillitis and obstructive tonsillar hypertrophy: answer from a histopathologic point of view.

Authors:  Ozan Bagis Ozgursoy; Ozgur Kemal; Mustafa Rahmi Saatci; Ozden Tulunay
Journal:  J Otolaryngol Head Neck Surg       Date:  2008-12
View more
  3 in total

1.  Microbiological Profile of Chronic Tonsillitis in the Pediatric Age Group.

Authors:  Raja Kalaiarasi; Kalaivani S Subramanian; Chellappa Vijayakumar; Ramakrishnan Venkataramanan
Journal:  Cureus       Date:  2018-09-22

2.  Tonsil histopathology in HIV-infected versus HIV-uninfected adults.

Authors:  Ridwaan Essa; Shivesh Maharaj; Kapila Hari; Shahpar Motakef
Journal:  South Afr J HIV Med       Date:  2019-05-28       Impact factor: 2.744

3.  Relation of Actinomyces with Tonsillar Hypertrophy and Antibiotic Use.

Authors:  Leyla Kansu
Journal:  Turk Arch Otorhinolaryngol       Date:  2017-03-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.